Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cellsNing Wu(CEA Grenoble), Jingfang Ju(Stony Brook University)OncotargetNovember 6, 201710.18632/oncotarget.22322Cited by 33SaveCiteExport RISWatch citationsRelated PapersmiR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer|Cell Death and Disease|2013|191Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1|Oncotarget|2017|59The miR-17 Family Links p63 Protein to MAPK Signaling to Promote the Onset of Human Keratinocyte Differentiation|PLoS ONE|2012|44